- Report
- February 2024
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
From €3327EUR$3,500USD£2,795GBP
From €3327EUR$3,500USD£2,795GBP
- Report
- October 2023
- 90 Pages
United States
From €3327EUR$3,500USD£2,795GBP
- Report
- October 2023
- 90 Pages
Israel
From €3327EUR$3,500USD£2,795GBP
- Report
- October 2023
- 89 Pages
Malaysia
From €3327EUR$3,500USD£2,795GBP
- Report
- October 2023
- 79 Pages
Malaysia
From €3327EUR$3,500USD£2,795GBP
- Report
- October 2023
- 88 Pages
Malaysia
From €3327EUR$3,500USD£2,795GBP
- Report
- October 2023
- 181 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2023
- 77 Pages
Canada
From €3327EUR$3,500USD£2,795GBP
- Report
- August 2023
- 76 Pages
Egypt
From €3327EUR$3,500USD£2,795GBP
- Report
- August 2023
- 79 Pages
Canada
From €3327EUR$3,500USD£2,795GBP
- Report
- August 2023
- 78 Pages
Israel
From €3327EUR$3,500USD£2,795GBP
- Report
- September 2023
- 200 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2024
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 132 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 96 Pages
North America
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP

The Implantable Cardioverter Defibrillator (ICD) market is a segment of the Cardiovascular Devices market. ICDs are medical devices used to treat life-threatening arrhythmias, or abnormal heart rhythms. They are implanted in the chest and monitor the heart's electrical activity. When an abnormal rhythm is detected, the device delivers an electrical shock to restore normal rhythm. ICDs are used to treat ventricular tachycardia and ventricular fibrillation, two of the most common causes of sudden cardiac death.
The ICD market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive treatments. The market is expected to grow at a steady rate over the forecast period.
Some of the major players in the ICD market include Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova, and Sorin Group. Show Less Read more